Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel regulatory protein (KCNRG) is a soluble, ER-associated protein found predominantly in lung tissue and other organs. It forms hetero-tetramers with voltage-gated potassium channels (Kv1 family), specifically interacting with the N-terminus (T1 domain) and inhibiting potassium channel activity by retaining these channels in the endomembrane system. KCNRG serves as a candidate tumor suppressor gene, as its activity is associated with reduced cell proliferation. Mutations or loss of KCNRG expression have been observed in various cancers, including hepatocellular carcinoma. KCNRG is also recognized as an autoantigen in autoimmune polyendocrine syndrome type 1 and may have roles in nonfatal respiratory diseases such as asthma and chronic bronchitis
KCNRG downregulates K+ channel activity by assembly interference or retention in endomembranes, leading to reduced cell proliferation by suppressing potassium channel activity and interfering with membrane potential dynamics. Loss or mutation of KCNRG function in disease may result in increased K+ channel activity and abnormal cell proliferation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel regulatory protein (KCNRG).